A Molecular Switch Abrogates Glycoprotein 100 (gp100) T-cell Receptor (TCR) Targeting of a Human Melanoma Antigen
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A Molecular Switch Abrogates Glycoprotein 100 (gp100) T-cell Receptor (TCR) Targeting of a Human Melanoma Antigen
Authors
Keywords
-
Journal
JOURNAL OF BIOLOGICAL CHEMISTRY
Volume 291, Issue 17, Pages 8951-8959
Publisher
American Society for Biochemistry & Molecular Biology (ASBMB)
Online
2016-02-26
DOI
10.1074/jbc.m115.707414
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Distortion of the Major Histocompatibility Complex Class I Binding Groove to Accommodate an Insulin-derived 10-Mer Peptide
- (2015) Chihiro Motozono et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A molecular switch in immunodominant HIV-1-specific CD8 T-cell epitopes shapes differential HLA-restricted escape
- (2015) Henrik N Kløverpris et al. Retrovirology
- Structural basis for ineffective T-cell responses to MHC anchor residue-improved “heteroclitic” peptides
- (2014) Florian Madura et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- An Altered gp100 Peptide Ligand with Decreased Binding by TCR and CD8α Dissects T Cell Cytotoxicity from Production of Cytokines and Activation of NFAT
- (2013) Niels Schaft et al. Frontiers in Immunology
- Different affinity windows for virus and cancer-specific T-cell receptors: Implications for therapeutic strategies
- (2012) Milos Aleksic et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- TCR/pMHC Optimized Protein crystallization Screen
- (2012) Anna M. Bulek et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Monoclonal TCR-redirected tumor cell killing
- (2012) Nathaniel Liddy et al. NATURE MEDICINE
- Structural and biophysical determinants of αβ T-cell antigen recognition
- (2011) John S. Bridgeman et al. IMMUNOLOGY
- TCRs Used in Cancer Gene Therapy Cross-React with MART-1/Melan-A Tumor Antigens via Distinct Mechanisms
- (2011) O. Y. Borbulevych et al. JOURNAL OF IMMUNOLOGY
- Wild-type and modified gp100 peptide-pulsed dendritic cell vaccination of advanced melanoma patients can lead to long-term clinical responses independent of the peptide used
- (2010) W. Joost Lesterhuis et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Modification of MHC Anchor Residues Generates Heteroclitic Peptides That Alter TCR Binding and T Cell Recognition
- (2010) D. K. Cole et al. JOURNAL OF IMMUNOLOGY
- Real time detection of peptide–MHC dissociation reveals that improvement of primary MHC-binding residues can have a minimal, or no, effect on stability
- (2010) Kim M. Miles et al. MOLECULAR IMMUNOLOGY
- T Cell Receptor Cross-reactivity Directed by Antigen-Dependent Tuning of Peptide-MHC Molecular Flexibility
- (2009) Oleg Y. Borbulevych et al. IMMUNITY
- xia2: an expert system for macromolecular crystallography data reduction
- (2009) G. Winter JOURNAL OF APPLIED CRYSTALLOGRAPHY
- Thermodynamics of T‐cell receptor–peptide/MHC interactions: progress and opportunities
- (2008) Kathryn M. Armstrong et al. JOURNAL OF MOLECULAR RECOGNITION
- Unmodified self antigen triggers human CD8 T cells with stronger tumor reactivity than altered antigen
- (2008) D. E. Speiser et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started